Carmela Bousada said in her first interview since she gave birth to twin boys on Dec. 29 that she sold her house in
Someone (Other Than You) May Own Your Genes
THE Food and Drug Administration’s recent declaration that food from cloned animals is safe was a fresh reminder of how poorly the biotech industry and its regulators have managed the field’s portfolio of innovation over the years.
A recent survey found that Americans overwhelmingly distrust government and industry to provide truthful information about biotech’s risks and safety. Yet equally important as risk — and more often overlooked — are the public’s equally real and unaddressed concerns about who is looking out for its interests as the genes of plants, animals and microbes, as well as entire organisms, become privatized through the patenting system.
Or is there?
That's a question being raised by scientists, activists and government bureaucrats since the Food and Drug Administration concluded in December that meat and milk from cloned animals should be allowed on the market.
In the opinion of some in the biotechnology arena…Cancer drugs: too toxic?
New drugs developed in the last decade can dramatically cut the chances that breast cancer will return. But as many as one-third of women stop taking the drugs before the end of the recommended five-year course of therapy, often because of the side effects.
The poor compliance worries doctors, who say women could be reducing their chance of survival.
"These are lifesaving drugs for these women," says Dr. Cary Presant, a clinical professor of medicine at USC and the author of a recent study on the side effects of these medications. "We want to see women continue taking them."
Like tamoxifen before them, the drugs, known as aromatase inhibitors, benefit women with estrogen-specific breast cancer, which constitutes about 80% of all breast cancers. In this type of disease, the tumors are fueled by the hormone estrogen.
Conservative Judicial Activism? Inventing a constitutional right to "medical self-defense."
Do you have a bright idea (albeit a controversial one) that you would like to see implemented as national policy? Would you prefer to achieve this without the inconvenience of having to persuade Congress and the president, let alone the American people? Well, here's how to do it.
“The number of women between the ages of 15 and 50 is fixed. The number of birth-giving machines (and) devices is fixed, so all we can ask is that they do their best per head,” Health, Labor and Welfare Minister Hakuo Yanagisawa said in a speech Saturday, the Asahi and Mainichi newspapers reported.
Patients who suffer from disease or injury that leave them unable to move have little hope of independent mobility. But that may be about to change. Researchers are developing a thought-controlled robotic wheelchair.
Other researchers have already had some success with hard-wired brain computer interfaces, but they're powered by large computers and are physically plugged into the brain.
The Spanish researchers hope to develop a small, mobile interface that works with electroencephalogram electrodes, or EEG, placed on the scalp.
"We are planning to use non-invasive devices to record the rhythms from the surface of the skull," says Javier Minguez, a researcher at the
The Spanish Ministry of Education and Science has invested 180,000 euros in the "Biomedical Evaluation Of Robots to Assist Human Mobility" project. The goal is to bring mobility and a degree of independence to people with limited motor capabilities as the result of injury, disability or old age.